Vaccine Therapy in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia
Clinical trial NCT00428077 · TERMINATED
Trial details
- NCT number
- NCT00428077
- Sponsor
- OHSU Knight Cancer Institute
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2005-10-01
- Primary completion
- 2009-04-01
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.